Xenomis Sees “Revolutionary” Results In Harvard-Developed Technology
This article was originally published in The Tan Sheet
Executive Summary
A technology that dietary supplement industry executive and investor William Watts has licensed from Harvard Medical School researchers could lead to a "major breakthrough" in health care, he says
You may also be interested in...
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers
Sure Nature Can “Kiss” ImmunaSure Ad Goodbye – NAD
Sure Nature claims its ImmunaSure dietary supplement can help "kiss your cold sores goodbye," but the National Advertising Division does not embrace the pitch